
Jefferies raises price target on U.S.-based agrichemicals company Corteva CTVA.N to $92 from $80; maintains "buy" rating
New PT is 27.5% upside to stock's last close
Brokerage says Corteva's leverage to increasing global acreage is a contrast to the concerns petrochemicals face over competitor supply additions
It expects Corteva's competitive gap with Bayer will likely narrow this cycle, as Genetically Modified Organisms (GMO) monopoly positions are harder to secure
Brokerage notes that CTVA benefits from rising fertilizer prices and the end of destocking in crop chemicals
18 out 25 brokerages rate the stock "buy" or higher, 7 "hold"; median PT is $72.55 - data compiled by LSEG
As of last close, CTVA up 25% YTD